









Markets
/
Stocks
/
nasdaq-camp
/

CAMP4 Therapeutics Corp

CAMP

3.840USD

+0.250+6.96%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

180.02MMarket Cap

LossP/E TTM



CAMP4 Therapeutics Corp

3.840

+0.250+6.96%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of CAMP4 Therapeutics Corp to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2023Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-15.72%-11.22M

---10.34M

---14.29M

---11.29M

-47.89%-9.69M

---6.55M

Net income from continuing operations

-11.98%-15.10M

---12.59M

---12.43M

---13.28M

-15.30%-13.48M

---11.70M

Operating gains losses

117.70%910.00K

--430.00K

--421.00K

--418.00K

-2.79%418.00K

--430.00K

Other non-cash items

4.70%490.00K

--384.00K

--586.00K

--479.00K

16.13%468.00K

--403.00K

Change in working capital

-128.13%-369.00K

--428.00K

---3.72M

--297.00K

-63.41%1.31M

--3.59M

-Change in prepaid expenses

-306.40%-419.00K

--317.00K

---7.00K

---368.00K

-76.83%203.00K

--876.00K

-Change in other current liabilities

--0.00

---385.00K

--385.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-15.72%-11.22M

---10.34M

---14.29M

---11.29M

-47.89%-9.69M

---6.55M

Investing cash flow

Net cash from continuing investing activities

---36.00K

--0.00

--279.00K

--263.00K

-100.00%0.00

--207.00K

Capital expenditures

--0.00

--279.00K

--263.00K

-100.00%0.00

--207.00K

Net cash flow from disposal of fixed assets

---36.00K

--0.00

--279.00K

--263.00K

-100.00%0.00

--207.00K

Net cash flow from other investing activities

--0.00

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

--36.00K

--0.00

---279.00K

---263.00K

100.00%0.00

---207.00K

Financing cash flow

Cash flow from continuous financing activities

12375.65%47.38M

--72.00K

---151.00K

--73.06M

-90.15%-386.00K

---203.00K

Net cash flow from debt Issuance/repayment

84.44%-14.00K

---43.00K

---36.00K

---96.00K

-1.12%-90.00K

---89.00K

Net cash flow from common stock issuance/repurchase

104938.71%32.56M

--0.00

--76.32M

3000.00%31.00K

--1.00K

Proceeds from stock option exercised by employees

--3.00K

----

--113.00K

----

Net cash flow from other financing activities

4636.09%14.83M

--115.00K

---115.00K

---3.27M

-184.35%-327.00K

---115.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

12375.65%47.38M

--72.00K

---151.00K

--73.06M

-90.15%-386.00K

---203.00K

Net cash flow

Beginning cash balance

185.83%40.68M

--50.95M

--65.66M

--4.15M

-75.90%14.23M

--59.06M

Current period cash flow changes

459.19%36.20M

---10.27M

---14.72M

--61.51M

-44.73%-10.08M

---6.96M

Ending cash balance

1751.61%76.88M

--40.68M

--50.95M

--65.66M

-92.03%4.15M

--52.09M

Free cash flow

-15.72%-11.22M

---10.34M

---14.56M

---11.55M

-43.37%-9.69M

---6.76M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

